Results 121 to 130 of about 10,970 (166)

Use of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in diagnosis of rheumatoid arthritis in a tertiary care hospital. [PDF]

J Family Med Prim Care
Mahadevaiah P, Yoganand R, Siddappa RG, Pooja P.   +3 more
europepmc   +1 more source

Anti-Cyclic Citrullinated Peptide Antibody as a Predictor of Rheumathoid Arthritis Complications. [PDF]

Med Arch, 2020
Mekic M, Hadzigrahic E.
europepmc   +1 more source

Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody. [PDF]

BMJ Open, 2021
Kamiya H, Panlaqui OM.
europepmc   +1 more source

HLA-B*44 is associated with a more than twentyfold increase in cyclic citrullinated peptide antibody serum level in Croatian patients with seropositive rheumatoid arthritis. [PDF]

PLoS One
Aljinović J, Kero D, Šošo D, Petrić M, Marasović Krstulović D, Perković D, Čečuk-Jeličić E, Jaman S, Dujmović D, Marinović I.   +9 more
europepmc   +1 more source

Effect of denosumab switched from bisphosphonates in preventing joint destruction in postmenopausal rheumatoid arthritis patients with anti-cyclic citrullinated peptide antibodies. [PDF]

J Orthop Surg Res, 2021
Mori Y, Izumiyama T, Kurishima H, Kamimura M, Baba K, Mori N, Itoi E.   +6 more
europepmc   +1 more source

Endogenous Retroelement Activation is Implicated in Interferon-α Production and Anti-Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis. [PDF]

Arthritis Rheumatol
Cooles FAH, Vidal Pedrola G, Naamane N, Pratt AG, Barron-Millar B, Anderson AE, Hilkens CMU, Casement J, Bondet V, Duffy D, Zhang F, Shukla R, Isaacs JD.   +12 more
europepmc   +1 more source

The development of anti-cyclic citrullinated peptide (Anti-CCP) antibody following severe COVID-19

, 2023
Roghani SA, Dastbaz M, Shamsi A, Abdan Z, Rostampour R, Soleymani B, Zamanian MH, Soufivand P, Pournazari M, Taghadosi M.   +9 more
europepmc   +1 more source

Rheumatoid factor and anti-cyclic citrullinated peptide antibody levels decline in rheumatoid arthritis patients treated with Janus kinase inhibitors or biological disease-modifying anti-rheumatic drugs. [PDF]

J Rheum Dis
Kim BY, Kim JW, Lee H, Park SH, Kim SK, Choe JY.   +5 more
europepmc   +1 more source

Rheumatoid Meningitis with Generalized Convulsions during Peficitinib Treatment, in Which Anti-cyclic Citrullinated Peptide Antibody in the Cerebrospinal Fluid Was Useful for Making a Diagnosis: A Review of the Literature and Previous Reports. [PDF]

Intern Med
Asatani S, Kitamura N, Uchikawa M, Sugito K, Nishihara M, Nagasawa Y, Inomata H, Akiya K, Oshima M, Nakamura H.   +9 more
europepmc   +1 more source

Rapid Microfluidic Biosensor for Point-of-Care Determination of Rheumatoid Arthritis via Anti-Cyclic Citrullinated Peptide Antibody Detection. [PDF]

Biosensors (Basel)
Tai WY, Chen TL, Wang HM, Fu LM.
europepmc   +1 more source